Background: Vitamin D deficiency during pregnancy has been associated with increased risk of complications and adverse perinatal outcomes. We evaluated seasonal variation of 25-hydroxyvitamin D [25(OH)D] among pregnant women, focusing on patterns and determinants of variation. Methods: Data came from three cohort studies in the US that included 2583 non-Hispanic Black and White women having prenatal 25(OH)D concentrations determined. Fourier time series and generalised linear models were used to estimate the magnitude of 25(OH)D seasonality. We modelled seasonal variability using a stationary cosinor model to estimate the phase shift, peak-trough difference, and annual mean of 25(OH)D. Results: We observed a peak for 25(OH)D in summer, a nadir in winter, and a phase of 8 months, which resulted from fluctuations in 25(OH)D3 rather than 25(OH)D2. After adjustment for covariates, the annual mean concentrations and estimated peak-trough difference of 25(OH)D among Black women were 19.8 ng/mL [95% confidence interval (CI) 18.9, 20.5] and 5.8 ng/mL [95% CI 4.7, 6.7], and for non-Hispanic White women were 33.0 ng/mL [95% CI 32.6, 33.4] and 7.4 ng/mL [95% CI 6.0, 8.9]. Conclusions: Non-Hispanic Black women had lower average 25(OH)D concentrations throughout the year and smaller seasonal variation levels than non-Hispanic White women. This study's confirmation of 25(OH)D seasonality over a calendar year has the potential to enhance public health interventions targeted to improve maternal and perinatal outcomes.
Vitamin D, a nutrient and a prohormone, is essential for normal absorption of calcium from the intestine. There are two mains forms: cholecalciferol (D3) and ergocalciferol (D2). The D3 form is obtained from synthesis in the skin with exposure to ultraviolet radiation (UVR) and from dietary sources such as oily fish and supplements. D2 is essentially only available from supplements as it is synthetically derived from plantbased sources. Both forms are metabolised in the liver to circulating 25-hydroxyvitamin D [25(OH)D2 and 25(OH)D3, herein denoted as 25(OH)D unless specified]. [1] [2] [3] [4] Serum 25(OH)D concentrations, the active metabolite used to assess vitamin D status, can vary substantially within individuals and across populations over the calendar year and are highest at the end of summer and lowest at the end of winter. 5 This variation is likely due to seasonal differences in sunlight intensity during summer when individuals receive more UVR exposure. 6 In addition to regulating calcium metabolism, vitamin D helps maintain normal concentrations of blood glucose, regulates hormonal secretions, and controls cellular growth and differentiation. 7 Vitamin D deficiency during pregnancy has received increased attention due to its association with increased risk of medical complications during pregnancy and other adverse perinatal outcomes including pre-eclampsia, 8, 9 gestational diabetes, 10, 11 and increased caesarean sections. 12 Studies have shown that maternal antepartum 25(OH)D concentration level is a strong predictor of newborn vitamin D status; 13, 14 infants of mothers with deficient vitamin D concentrations experience depleted vitamin D concentrations in utero and are born with low vitamin D stores that must carry them through the first few months of life. 13, 15 Seasonal and racial disparities of 25(OH)D serum concentrations have been described in specific subgroups of the general US population. 16 Blacks synthesise less cutaneous vitamin D than other racial groups. 17, 18 Studies have found racial disparities of 25(OH)D among pregnant women, with Black pregnant women having lower concentrations compared with White pregnant women. 19 While a clear seasonal pattern in 25(OH)D was observed for White pregnant women, seasonal variation was not observed for Black pregnant women, in part due to limited sample size. 20 Increasing our understanding of seasonal variability of vitamin D among pregnant women could have a tremendous public health impact as it can inform clinical vitamin D supplementation strategies and behaviour recommendations for pregnant women of all races.
Therefore, we aimed to evaluate and describe seasonal variability of vitamin D focusing on patterns and determinants of variation among non-Hispanic Black and White pregnant women by geographical and maternal sociodemographic characteristics. We also aimed to examine the extent to which seasonal changes of 25(OH)D are principally due to the variability of vitamin D2 or D3.
Methods

Data and study settings
Data used for this research were drawn from three prospective cohort studies of pregnant women; each of the studies included a questionnaire, medical records, and archived serum samples. Participating cohorts included the Omega study, the Pregnancy, Infection and Nutrition (PIN) study, and the Pregnancy Outcomes and Community Health (POUCH) study. Detailed descriptions of the cohorts are published. [21] [22] [23] Briefly, investigators in the Omega study (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) prospectively followed pregnant women attending prenatal care clinics affiliated with the Swedish Medical Center and Tacoma General Hospital in Seattle and Tacoma, Washington, respectively. The Omega study was designed to assess the influence of maternal diet, physical activity, and other life style characteristics on the incidence of preeclampsia, gestational diabetes mellitus, and other adverse pregnancy outcomes. In the PIN study, pregnant women were recruited from selected prenatal care clinics in North Carolina over three study waves: PIN1 (1995-2005), PIN2 (1999) (2000) (2001) , and PIN3 (2000) (2001) (2002) (2003) (2004) (2005) . The PIN study was designed to investigate the role of infections, stress, physical activity, and nutrition on preterm delivery. Investigators of the POUCH study (1998) (1999) (2000) (2001) (2002) (2003) (2004) prospectively followed pregnant women recruited at the time of maternal serum alphafetoprotein screening during prenatal visits from 52 select clinics in five Michigan communities. POUCH was designed to investigate infectious, maternal vascular disease, and stress pathways to preterm delivery.
In all three cohorts, participants were invited to provide blood samples and participate in an in-person interview at enrolment. Collected maternal blood samples were frozen at −70°C and stored until analysis. Our study included data from women who were enrolled in a cohort at less than 29 weeks of gestation and who completed enrolment and had a single initial blood draw prior to 29 weeks of gestation. The present study was restricted to singleton pregnancies among non-Hispanic Black and White women sampled as part of a multi-cohort, nested case-control study. 24 Maternal medical records were abstracted, and we included women who had information on 25(OH)D serum concentration ascertained with the pregnancy week at draw and date of draw. After these restrictions, this study's final sample size included 2583 pregnant women who delivered preterm (870) or at term (1713).
Ethical approval for each study was granted by the Institutional Review Boards (IRB) at the respective institution (Swedish Medical Center and Tacoma General Hospital for Omega, University of North 25 Samples from each cohort were assayed together with separate runs by cohort. Before analysis, serum samples were derivatised with 4-phenyl-1,2,4-triazoline-3,5-dione to improve sensitivity of assays at low concentration of analyte. 26 Structural epimers were not assayed. The lower limits of detection for 25(OH)D3 and 25(OH)D2 were 0.6 and 1.1 ng/mL, respectively. For quality control purposes, we used standard reference material 972 levels 1-4 from the U.S. National Institute of Standards and Technology. 27 The mean coefficients of variation (CV) for 25(OH)D3 were 9.5% at 12.3 ng/mL and 8.3% at 70.7 ng/mL. For 25(OH)D2, the mean CVs were 28.8% at 2.8 ng/mL and 10.7% at 25.4 ng/mL.
We assessed the heterogeneity between and within cohort-specific estimates for 25(OH)D and used the DerSimonian and Laird Q statistic to test 25(OH)D heterogeneity between studies. The Q statistic was consistent with homogeneity across the studies, thus indicating that the data could be combined across cohorts (P = 0.11). Nevertheless, due to the small number of studies (n = 3) and consequently low statistical power of the tests, we visually examined the overlap of cohort-specific mean 25(OH)D and confidence intervals (CI) in a forest plot. These data visualisation exercises confirmed the likelihood of homogeneity of 25(OH)D mean concentrations across the three cohorts.
28,29
Covariates
We limited covariate assessment to those similarly defined in all three cohorts. These include selfreported maternal race and Hispanic origin (nonHispanic Black and non-Hispanic White), maternal age at blood draw, educational level (high school or less, post-high school), and prepregnancy body mass index (BMI). Prepregnancy BMI was calculated from maternal height via interview and self-reported prepregnancy weight; BMI scores were categorised as: <25 (normal), 25-29.9 (overweight), and ≥30 (obese) kg/m 2 . 30 We created a variable aggregating months into the four seasons of the northern hemisphere at the blood sample draw date (winter: December to February, spring: March to May, summer: June to August and fall: September to November).
Statistical analysis
First, we graphically assessed the presence of seasonality in the distribution of the observed serum concentrations of 25(OH)D using a time plot and a lowess adjustment based on the data. 31 After identifying a seasonal pattern, we developed an observational Fourier analysis to determine the highest frequency (or dominant period) of 25(OH)D serum concentrations over time. We used a time series periodogram to compute the highest frequency to cover a seasonal cycle in the observed serum concentrations of 25(OH)D. 32 Second, we described the pooled and stratified covariates in analysis by study site, presenting counts and percentages for categorical variables. To describe 25(OH)D seasonality, we used data reduction. 33 We then grouped the data into four seasons and determined the mean and standard deviation of 25(OH)D serum concentrations presented by study site and maternal race.
Third, we assessed the monthly variability of 25(OH)D over a period of 12 months by fitting a generalised linear model with robust standard error estimation, assuming a normal distribution of the 25(OH)D distribution, and an identity link. 34 We then used the Dickey-Fuller test to confirm the stationary of 25(OH)D serum concentrations over time (i.e. peak-trough differences remaining constant over time) to develop a stationary cosinor models. 33, 35, 36 In cosinor models, the dependent variable 25(OH)D was modelled as a sine wave characterised by a phase shift (i.e. location of peak and trough concentrations on the time axis) and amplitude (i.e. maximum variation of the sine wave from its mean height). The time (t) variable (month) was transformed as cosine(t) and sine(t), which were then fit as predictors of 25(OH)D. The resulting coefficients of the cosine(t) and sine(t) were then transformed to derive the total peaktrough difference (which is equal to twice the amplitude) and the marginal annual mean (i.e. the intercept term of the model). Adjustment for other covariates effects on the yearly mean of 25(OH)D is accomplished by adding terms to the regression model. 16, 33 We adjusted derived marginal annual means of 25(OH)D and peak-trough differences for the main effects of maternal age, race, and study site.
In adjusted cosinor models, we centred study site and maternal age and race at their study means, so that the reported annual mean of 25(OH)D concentration was standardised to the mean covariate values of the study population. 16 We used the Delta method to derive standard errors and CI of the derived adjusted means and peak-trough differences. 37 Finally, we explored the sensitivity of our estimates to alternative model specifications. All analyses were completed using stata v.12.1 (StataCorp, College Station, TX, USA).
Results
Women in the Omega study were older and more likely to be non-Hispanic White (96.4%), to have had higher educational attainment levels (95.5% posthigh school), and lower prepregnancy BMI (73.1% under 25) compared with women in the PIN and POUCH studies. There were only 27 non-Hispanic Black women in Omega study, and their sociodemographic and life style characteristics differed as compared with their counterparts in the PIN and POUCH cohorts. For example, non-Hispanic Black women in Omega study were older, better educated, and had lower prepregnancy BMI as compared with their counterparts in the PIN and POUCH studies, respectively.
The frequency distribution of the season of blood collection did not differ considerably across the three study cohorts (Table 1) .
The time plot indicates the presence of a seasonal pattern with a sinusoidal distribution of 25(OH)D serum concentrations over time (Figure 1) . The Fourier series analysis based on the periodogram shows a peak at a frequency of 0.083, which corresponds with the highest frequency observed in the data. This peak reflects a cycle of 12 months and confirms the presence of a seasonal pattern as illustrated in the time plot (Figure 2 ). The Dickey-Fuller test further confirms the stationary of 25(OH)D concentrations over time (P < 0.001) with constant seasonal peak-trough differences during the period in analysis.
Observed annual mean of 25(OH)D serum concentrations by season show a peak at the end of the summer and a nadir in winter. Compared with (Figure 4) .
Regarding the amplitude of seasonal variation, nonHispanic White race, women aged between 25 and 34 years, with normal BMI, and with post-high school education show greater peak-trough differences in 25(OH)D concentrations (sine wave amplitude). The PIN study has the lowest annual peak-trough and mean serum concentrations of 25(OH)D while the POUCH study the highest (Table 4) .
As indicated in Figure 5 , regardless of maternal age and study site, non-Hispanic Black women have lower annual mean 25(OH)D serum concentrations (with concentrations <20 ng/mL from November through April) ( Figure 5 ).
Lastly, given that non-Hispanic Black women from the Omega study differed from those in the PIN and POUCH studies, we completed sensitivity analyses after excluding Omega study (n = 27) participants.
Findings from these sensitivity analyses were similar to those from our primary analyses. For example, after adjustment for covariates, the annual mean concentrations of 25(OH)D among non-Hispanic Black women were 19.2 ng/mL in the restricted analysis (19.8 ng/mL in the primary analysis). The corresponding value for estimated peak-trough differences of 25(OH)D among non-Hispanic Black women in the restricted cohort was 5.9 ng/mL (5.8 ng/mL in the primary analysis). As the source of 25(OHD)D2 is primarily supplements, and not UVR, the lack of seasonal variability in this form is not surprising.
To the best of our knowledge, this is the largest study to evaluate seasonal variation of 25(OH)D concentration among pregnant US women and the first study to reveal a seasonal pattern of 25(OH)D serum concentrations among US non-Hispanic Black pregnant women. Our study utilised rigorous analytic approaches that consider gestational age at collection time.
Our study results are also consistent with prior studies reporting seasonal variation of serum community-based older adults demonstrated a sinusoudal variation of serum 25(OH)D concentrations thoughout the calender year. 16 Similarly, Bolland et al. found that seasonal variation of 25(OH)D serum concentrations significantly affects the diagnosis of vitamin D sufficiency, which requires seasonally adjusted thresholds. 38 Collectively, the results of our study and those of others, show that consideration of seasonality variation is necessary to develop assesment of vitamin D deficiency and vitamin D supplementation strategies.
A substantial body of evidence shows that Black women synthesise less cutaneous vitamin D compared with White women. 17, 18 The skin pigment melanin absorbs UVR photons and can reduce 25(OH)D3 synthesis. 18 Consequently, many African Americans are at higher risk of vitamin D deficiency. . 20 The authors speculate that Black women are unable to accumulate adequate concentrations of vitamin D when sunlight increases in summer, based on their findings of no significant variability of 25(OH)D serum concentrations over the astronomical calendar year. However, their study was limited by a small sample size.
Our results show that the variability of 25(OH)D among non-Hispanic Black pregnant women follows a clear seasonal pattern, which is likely due to differences in exposure to UVR. 7, 33 This pattern of seasonality is characterised by higher serum concentrations of 25(OH)D during summer months (June to August) and lower concentrations in winter months (December through February), when less UVR reaches the earth, minimising the quantity of vitamin D that can be synthesised by the skin. 39, 40 On the other hand, differences in sunlight exposition and skin pigmentation among pregnant women might not be the only factors that explain racial differences of 25(OH)D serum concentrations. Other factors could explain racial 25(OH)D inequalities, such as obesity, diet, educational attainment, smoking status, and/or socio-economic status. [41] [42] [43] One limitation of the present study is the reduced availability of determinants of variation in 25(OH)D serum concentrations in our data, such as diminished sunlight exposure. 44 Regardless of latitude and seasonality, diminished sunlight exposure could be affected by social conventions, sunscreen use, air pollution levels (e.g. urban vs. suburban) and degree of regular outdoor physical activity. 45, 46 Hence, if factors associated with diminished sunlight exposure had been considered in our analysis, the observed racial differences in vitamin D concentrations may have been attenuated. In addition, differences found among non-Hispanic White women, with the highest concentrations of 25(OH)D in Michigan, which is much further north than North Carolina, may be explained by diminished sunlight exposure due to time spent outdoors or due variations in use of sunscreen or clothing options and styles. Future studies will benefit from including assessment of these and other behavioural factors that may account for unexpected variations in 25(OH)D concentrations according to study site.
Other limitations include lack of data on dietary or supplemental sources of vitamin D and smoking status. Vitamin D supplementation during pregnancy is usually limited to prenatal care vitamins or fortified foods. Although we do not have information on prenatal Vitamin D use, no changes have been reported for the current US vitamin D supplementation guidelines of 400 IU daily for pregnant women. 47 Thus, our results should not have been affected by a time period effect regarding vitamin D use. Moreover, having run the samples of each cohort separately in the laboratory might have induced potential batch run differences. Recent studies have shown that vitamin D supplementation of 4000 IU/day during pregnancy improved maternal vitamin D status throughout pregnancy and improved vitamin D status at birth. 48, 49 However, assessing vitamin D sufficiency may require seasonally adjusted thresholds based on collection time. 38 Thus, as our study indicates, increased knowledge about the patterns and determinants of variability of 25(OH)D among pregnant women could serve to better inform clinical care decision making so as to prevent adverse maternal and perinatal outcomes caused by vitamin D deficiency.
In summary, this study's confirmation of 25(OH)D seasonality over the calendar year in a population of pregnant US women can enhance public health interventions targeted to improve maternal and perinatal outcomes. Vitamin D supplements and behaviour recommendations to maximise skin production, balancing the risk to sun exposure, should be recommended during pregnancy with consideration of racial subgroups of pregnant women who are at higher risk of vitamin D deficiency, specifically dark-skinned pregnant women.
